Sanofi is revising its takeover offer for Ocular Therapeutix after the U.S. biotech rejected the French drugmaker's initial $16 per share proposal, according to recent filings and market reports. ...
```html Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Helvetica Neue', sans-serif; line-height:...
Johnson & Johnson (NYSE: JNJ) secured a partial victory from Delaware's Supreme Court, overturning a key element of a $1 billion damages award tied to its 2019 $3.4 billion acquisition of...
Medtronic is aggressively pursuing **tuck-in M&A** in the **low- to mid-single-digit billion-dollar range**, targeting cardiology and neuroscience to accelerate growth amid a resurgent **MedTech M&A...
A U.S. District Court ruling on January 9, 2026, has permanently halted Edwards Lifesciences' proposed $945 million to $1.2 billion acquisition of JenaValve Technology, following a Federal Trade...
Eli Lilly’s $1.2 billion all-cash acquisition of Ventyx Biosciences is a targeted move to secure a differentiated, oral NLRP3 franchise and expand its footprint across cardiometabolic,...
```html AbbVie Inc. is in advanced talks to acquire Revolution Medicines, a clinical-stage precision oncology company, in a deal valued at approximately $20 billion or more—a significant premium to...
A cannabis staffing company has accused its **CEO** of concealing ownership in a direct competitor during **merger negotiations**, potentially exposing the deal to **fiduciary duty lawsuits**,...
Alcon Inc. (NYSE: ALC) has officially terminated its $1.6 billion merger agreement with STAAR Surgical Company (NASDAQ: STAA) after STAAR shareholders rejected the deal on January 6, 2026, due to...
Hisamitsu Pharmaceutical, the Japanese maker of the iconic **Salonpas pain-relief patches**, is on the cusp of a management-led buyout valuing the company at around ¥450 billion ($2.9 billion), as...
